Analyze Diet
Annals of the New York Academy of Sciences1996; 791; 318-332; doi: 10.1111/j.1749-6632.1996.tb53539.x

Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.

Abstract: No abstract available
Publication Date: 1996-07-23 PubMed ID: 8784513DOI: 10.1111/j.1749-6632.1996.tb53539.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Cite This Article

APA
Roy P. (1996). Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease. Ann N Y Acad Sci, 791, 318-332. https://doi.org/10.1111/j.1749-6632.1996.tb53539.x

Publication

ISSN: 0077-8923
NlmUniqueID: 7506858
Country: United States
Language: English
Volume: 791
Pages: 318-332

Researcher Affiliations

Roy, P
  • Laboratory of Molecular Biophysics, University of Oxford, United Kingdom.

MeSH Terms

  • African Horse Sickness / immunology
  • African Horse Sickness / prevention & control
  • Animals
  • Antigens, Viral / biosynthesis
  • Baculoviridae
  • Bluetongue / immunology
  • Bluetongue / prevention & control
  • Capsid / biosynthesis
  • Cell Line
  • Epitopes
  • Genes, Viral
  • Horses
  • Immunization
  • Protein Structure, Secondary
  • Recombinant Proteins / biosynthesis
  • Sheep
  • Spodoptera
  • Vaccines, Synthetic
  • Viral Vaccines

Citations

This article has been cited 4 times.
  1. Calvo-Pinilla E, Marín-López A, Utrilla-Trigo S, Jiménez-Cabello L, Ortego J. Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design. Curr Opin Virol 2020 Oct;44:49-56.
    doi: 10.1016/j.coviro.2020.06.003pubmed: 32659516google scholar: lookup
  2. Sunwoo SY, Noronha LE, Morozov I, Trujillo JD, Kim IJ, Schirtzinger EE, Faburay B, Drolet BS, Urbaniak K, McVey DS, Meekins DA, Palmer MV, Balaraman V, Wilson WC, Richt JA. Evaluation of A Baculovirus-Expressed VP2 Subunit Vaccine for the Protection of White-Tailed Deer (Odocoileus virginianus) from Epizootic Hemorrhagic Disease. Vaccines (Basel) 2020 Jan 31;8(1).
    doi: 10.3390/vaccines8010059pubmed: 32023812google scholar: lookup
  3. Calvo-Pinilla E, Gubbins S, Mertens P, Ortego J, Castillo-Olivares J. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host. Antiviral Res 2018 Jun;154:132-139.
  4. Lu S, Wang S. Technical transformation of biodefense vaccines. Vaccine 2009 Nov 5;27 Suppl 4(0 4):D8-D15.
    doi: 10.1016/j.vaccine.2009.08.055pubmed: 19837293google scholar: lookup